Assignee
NIU DEQIANG
US·8 granted patents·5 pending applications·56 citations·filing 2007–2012
Top patents by PatentIndex Score
13 records- 0193US8741837B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2012·Granted Jun 3, 2014·10 cites·23 claims
- 0292US8524760B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2012·Granted Sep 3, 2013·9 cites·13 claims
- 0392US8293705B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2009·Granted Oct 23, 2012·12 cites·15 claims
- 0492US8188137B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2009·Granted May 29, 2012·13 cites·29 claims
- 0588US8778877B2HCV protease inhibitors and uses thereofNIU DEQIANG·Filed 2008·Granted Jul 15, 2014·10 cites·26 claims
- 0675US8501681B2Macrocyclic hepatitis C virus serine protease inhibitorsNIU DEQIANG·Filed 2007·Granted Aug 6, 2013·2 cites·15 claims
- 0761US2008279821A1Arylpiperidinyl and arylpyrrolidinyl macrocyclic hepatitis c serine protease inhibitorsNIU DEQIANG·Filed 2008·Application pending·0 cites
- 0859US2009005387A1Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitorsNIU DEQIANG·Filed 2008·Application pending·0 cites
- 0956US8809264B2Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitorsNIU DEQIANG·Filed 2007·Granted Aug 19, 2014·0 cites·15 claims
- 1053US2008317712A1Arylpiperidinyl and arylpyrrolidinyl tripeptide hepatitis c serine protease inhibitorsNIU DEQIANG·Filed 2008·Application pending·0 cites
- 1152US8962551B2Quinoxalinyl derivativesNIU DEQIANG·Filed 2008·Granted Feb 24, 2015·0 cites·15 claims
- 1251US2008287449A1Aza-tripeptide hepatitis c serine protease inhibitorsNIU DEQIANG·Filed 2008·Application pending·0 cites
- 1347US2008267917A1N-functionalized amides as hepatitis c serine protease inhibitorsNIU DEQIANG·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NIU DEQIANG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →